Fatal cases of human infection with avian influenza A (H7N9) virus in Shanghai, China in 2013

BioScience Trends

Volumn 9, Issue 1, 2015, Pages 73-78

  Shen, Yinzhong ^a   Lu, Hongzhou ^a   Qi, Tangkai ^a   Gu, Yong ^a   Xiang, Ming ^a   Lu, Shuihua ^a   Qu, Hongping ^b   Zhang, Wenhong ^c   He, Jian ^d   Cao, Huifang ^e   Ye, Jun ^f   Fang, Xucheng ^g   Wu, Xianzheng ^h   Zhang, Zhiyong ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c FUDAN UNIVERSITY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e Central Hospital in jing'An District   (China)

^f SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^g Shidong Hospital of Shanghai Yangpu District   (China)

^h TONGJI UNIVERSITY   (China)

Author keywords

Antiviral treatment; Avian influenza A (H7N9) virus; Death; Diagnosis

Indexed keywords

AVES; INFLUENZA A VIRUS;

ANTIVIRUS AGENT; OSELTAMIVIR;

CHINA; CITY; EPIDEMIOLOGY; HUMAN; INFLUENZA A VIRUS (H7N9); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MEDICAL RECORD; MORTALITY; RETROSPECTIVE STUDY; VIROLOGY;

ANTIVIRAL AGENTS; CHINA; CITIES; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MEDICAL RECORDS; OSELTAMIVIR; RETROSPECTIVE STUDIES;

EID: 84924901506     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2014.01113     Document Type: Article

References (9)

1. Gao R, Cao B, Hu Y, et al. Human Infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013; 368: 1888-1897.
2. Li Q, Zhou L, Zhou M, et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med. 2014, 370: 520-532.
3. Uyeki TM, Cox NJ. Global concerns regarding novel influenza A (H7N9) virus infections. New Engl J Med. 2013; 368: 1862-1864.
4. Shen Y, Lu H. Human infection with avian influenza A(H7N9) virus in Shanghai: current status and future trends. Chin Med J (Engl). 2014; 127: 1973-1976.
5. Gao HN, Lu HZ, Cao B, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013; 368: 2277-2285.
6. Tran TH, Nguyen TL, Nguyen TD, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350: 1179-1188.
7. Hu Y, Lu S, Song Z, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet. 2013; 381: 2273-2279.
8. Viasus D, Paño-Pardo JR, Pachón J, Riera M, López-Medrano F, Payeras A, Fariñas MC, Moreno A, Rodríguez-Baño J, Oteo JA, Ortega L, Torre-Cisneros J, Segura F, Carratalà J; Novel Influenza A(H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI). Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection. Chest. 2011; 140: 1025-1032.
9. Rodríguez A, Díaz E, Martín-Loeches I, et al. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother. 2011; 66: 1140-1149.